No Data
No Data
No Data
No Data
No Data
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
LA JOLLA, CA, April 29, 2024 — GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the tre
GRI BIOApr 29 00:00 ET
GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments
GRI Bio (GRI) said Tuesday South Korea's Korean Intellectual Property Office has granted a patent for liver inflammatory condition treatments. The patent covers compositions and methods for modulating
MT NewswiresApr 16 14:59 ET
Express News | GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (Nkt) Cell Modulators With Issuance of Korea Patent
Moomoo 24/7Apr 16 08:35 ET
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators With Issuance of Korea Patent
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovationContinued advancement of an innovative pipeline of NKT cell modulato
GRI BIOApr 16 00:00 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
BenzingaApr 8 16:31 ET
GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
LA JOLLA, CA, April 08, 2024 — GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Company"), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the t
GRI BIOApr 8 00:00 ET
No Data
No Data